The Investment Thesis The investment thesis for Cardiol Therapeutics (Cardiol), TSX:CRDL; OTC:CRTPF, encompasses the following key points: The Cannabidiol (CBD) market could turn into a $100B+ plus market globally. Cardiol has an efficient manufacturing process that allows them to produce 100% pure CBD while bypassing the capital investment and timeframe required by hemp-based extraction companies … Continue reading Company Overview: Cardiol Therapeutics